For this study the investigators aim to see if giving participants an oral HIV prevention medication on a medical van, is a good option of care for individuals who inject drugs and/or are sexually active and therefore at a higher risk of contracting HIV.
The purpose of this study is to evaluate a pilot program that provides Pre-Exposure Prophylaxis (PrEP) for people who use drugs (PWUD) and are at risk for contracting HIV. Given the ongoing overdose crisis and the risk of HIV among PWUD, this study aims to assess weather offering oral PrEP on a Medical Mobile Unit (MMU) is a viable strategy for preventing HIV transmission in high-risk populations. The other goal of this study is to assess community perceptions of PrEP and perceived HIV risk among Syringe Service Program (SSP) clients visiting a MMU.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
PREVENTION
Masking
NONE
Enrollment
20
Oral Pre-Exposure Prophylaxis (PrEP) pills
Duke Department of Population Health Sciences
Durham, North Carolina, United States
RECRUITINGEnrollment
Number of participants utilizing medical mobile unit during study duration who are eligible for PrEP
Time frame: Baseline
Negative HIV Status
Number of participants who remain HIV negative at 3 months (Measured via negative HIV test at 3 months
Time frame: up to 3 months
PrEP Consultation
Number of participants who agree to PrEP consultation
Time frame: up to 6 months
PrEP Initiation
Number of participants who complete PrEP consultation and start PrEP
Time frame: up to 6 months
Retention
Number of participants who come back for 3 month and 6 month visit
Time frame: up to 6 months
Follow Through
Number of participants who pick up PrEP medication
Time frame: up to 6 months
Negative HIV Status at 6 months
Number of participants who remain HIV negative at 6 months (Measured via negative HIV test at 6 months)
Time frame: up to 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.